Oligos for commercial and bulk supply 1

Oligos for commercial and bulk supply – cooperation with QIAGEN Strategic Partnerships & OEM (Asia & Australia)

The post-COVID-19 market moves fast. Many products in biotechnology rely on the quick and flexible production of high-quality oligonucleotides such as primers, probes, NGS adaptors, SCORPIONS and more. In this webinar, we give you an insider’s look at the production of oligos for commercial and bulk supply by QIAGEN DNA Synthesis, including what we offer, our customization capabilities and our flexibility to scale production according to your needs. In addition, we introduce QIAGEN Strategic Partnerships & OEM, which offers access to our nearly 40 years of industry-leading experience in a tight working relationship.

We look forward to meeting you at the webinar. Let’s accelerate your innovation, together.

About the speaker

Ali Ameri, Head of Business Strategy at QIAGEN DNA Synthesis

QIAGEN

Ali is the Head of Business Strategy at QIAGEN DNA Synthesis. He holds a Master Degree of Science in Chemical engineering and analytical chemistry. Over the past 16 years at QIAGEN, he has worked in Quality Control, Product and Process Development, Project Management, Technology Development, Customer Support and Marketing. He has experience in research & development area, engineering and separation chemistry.

Sonja Winnergren, Global Product Manager at QIAGEN DNA Synthesis

QIAGEN

Sonja is currently a Global Product Manager at QIAGEN DNA Synthesis. She holds a Master of Science in Biotechnology. Over the last 16 years at QIAGEN, Sonja has worked in Oligo Manufacturing, Customer Support, Marketing and Project Management. She has experience in research & development area, engineering, strategy, marketing and sales and as a certified project manager.